Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2025 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkor
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to The Report
Fundraising

Gilead Sciences

Gilead Sciences Raises $100B in Public

1987
Founded
17000+
Employees
333 Lakeside Drive, Foster City, CA 94404
Updated January 1, 2024
2 min read

Quick Facts

Gilead Sciences Raises $100B in Public


Gilead Sciences has successfully raised $100B in a Public at a $110B valuation led by Public.


Company Overview


Gilead Sciences is a Biotech company headquartered in 333 Lakeside Drive, Foster City, CA 94404, founded in 1987 with 17000+ employees.


Biopharmaceutical company


Fundraising Details


  • Amount Raised: $100B
  • Round Type: Public
  • Valuation: $110B
  • Date: 2024-01-01
  • Investors: Public

About Gilead Sciences


Biopharmaceutical company The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 333 Lakeside Drive, Foster City, CA 94404
  • Founded: 1987
  • Team Size: 17000+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Gilead Sciences's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Gilead Sciences's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $110B valuation marks an important milestone for Gilead Sciences, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Gilead Sciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Gilead Sciences, visit their headquarters at 333 Lakeside Drive, Foster City, CA 94404.

Topics

Fundraising(2912)Public(771)BiotechGilead Sciences

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million